RNAI Technology Market Size, Share reveals significant growth through 2022

The MarketWatch News Department was not involved in the creation of this content.

Nov 24, 2020 (AmericaNewsHour) —
Kenneth Research published a report on ‘RNAI TECHNOLOGY MARKET’ recently which gives a comprehensive insight into the current RNAI Technology Market environment. The report provides an in-depth analysis of the RNAI Technology Market on the basis of size, volume, and compound annual growth rate (CAGR) during the forecast period, i.e., 2020-2022.

According to WHO, the true state of health of a population is revealed by Healthy Life Expectancy (HALE). HALE not only considers the number of years a person lives, but also if they lived in good health. Between 2000 and 2016, HALE increased globally from 59 years to 63 years which is a growth of 8%. Around USD 7.5 trillion is spent globally on healthcare each year and to achieve targets for primary health care, an additional investment of USD 200

Read More

RNAI Technology Market Opportunities, Value Chain and Sales Channels Analysis 2022

The MarketWatch News Department was not involved in the creation of this content.

Nov 19, 2020 (AmericaNewsHour) —
Kenneth Research published a report on ‘RNAI TECHNOLOGY MARKET’ recently which gives a comprehensive insight into the current RNAI Technology Market environment. The report provides an in-depth analysis of the RNAI Technology Market on the basis of size, volume, and compound annual growth rate (CAGR) during the forecast period, i.e., 2020-2022.

According to WHO, the true state of health of a population is revealed by Healthy Life Expectancy (HALE). HALE not only considers the number of years a person lives, but also if they lived in good health. Between 2000 and 2016, HALE increased globally from 59 years to 63 years which is a growth of 8%. Around USD 7.5 trillion is spent globally on healthcare each year and to achieve targets for primary health care, an additional investment of USD 200

Read More

Dicerna Presents New Nonclinical Research Highlighting the Application of its RNAi Technology in Extrahepatic Tissues at TIDES Europe 2020

Dicerna Pharmaceuticals, Inc. (Nasdaq: DRNA) (the “Company” or “Dicerna”), a leading developer of investigational ribonucleic acid interference (RNAi) therapeutics, today announced that Marc Abrams, Ph.D., vice president of discovery research, will present an update on the Company’s early-stage development of extrahepatic RNAi therapeutics at TIDES Europe: Oligonucleotide & Peptide Therapeutics, a virtual conference taking place Nov. 11-13, 2020.

The presentation, titled, “Progress on a Pipeline of Extrahepatic RNAi Therapeutics,” includes nonclinical data demonstrating messenger RNA (mRNA) knockdown activity in multiple extrahepatic tissues using therapeutic nucleic acid modalities leveraging Dicerna’s proprietary RNAi technology. The presentation will be available from the conference website as part of the Oligonucleotide Discovery, Preclinical and Clinical track of TIDES Europe and will be viewable online for 30 days following the conference. The slides from the presentation will also be made available on the Events & Presentations page of Dicerna’s corporate website.

“Since introducing our proprietary GalXC™

Read More

RNAi Technology Market- Future Scope, Demands and Projected Industry Growths, 2027

New York, United States, Fri, 23 Oct 2020 07:01:04 / Comserve Inc. / — According to the National Cancer Institute, it was estimated that in 2018, around 1,735,350 new cases of cancer would be diagnosed in the United States, out of which, 609,640 people were estimated to die from the disease.

Research Nester released a report titled “RNAi Technology Market: Global Demand Analysis & Opportunity Outlook 2027” which delivers detailed overview of the global RNAi technology market in terms of market segmentation by therapy area, by application and by region.

Further, for the in-depth analysis, the report encompasses the industry growth drivers, restraints, supply and demand risk, market attractiveness, BPS analysis and Porter’s five force model.

According to the National Cancer Institute, it was estimated that in 2018, around 1,735,350 new cases of cancer would be diagnosed in the United States, out of which, 609,640 people were estimated to die

Read More